AMGN vs BAX
By Alex · Tickerpine
Amgen Inc. vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | BAX |
|---|---|---|
| Price | $358.33 | $22.04 |
| Market cap | $193.39B | $11.38B |
| P/E ratio | 24.9 | — |
| ROE | 101.32% | -15.01% |
| Profit margin | 20.96% | -9.70% |
| Revenue growth | 5.80% | 2.90% |
| Dividend yield | 2.81% | 0.91% |
| Beta | 0.42 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs BAX in plain English
- AMGN is the bigger company — about 17.0× the market cap of BAX.
- AMGN earns a higher return on equity (101% vs -15%).
- AMGN is growing revenue faster (6% vs 3%).
- AMGN has the higher dividend yield (2.81% vs 0.91%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.